SCHEMBL3789565

SCHEMBL3789565

CN(C)c1ccc(Cl)cc1N(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.61
KMT2A Q03164 1/20 0.61
FSCN1 Q16658 1/20 0.45
KCNH2 Q12809 1/20 0.43
POLB P06746 1/20 0.40
MAPK1 P28482 1/20 0.40
BLM P54132 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 2/20 0.39
TP53 P04637 1/20 0.38
MAT2A P31153 1/20 0.37
MCL1 Q07820 1/20 0.36
CCR5 P51681 1/20 0.36
CHKA P35790 2/20 0.36
CYP3A4 P08684 2/20 0.36
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
LMNA P02545 1/20 0.35
CYP2A6 P11509 1/20 0.35
CHUK O15111 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1039636 0.82 GAA (0.54) GAAKMT2AFSCN1KCNH2POLB
SCHEMBL2616324 0.82 GAA (0.59) GAAKMT2AFSCN1KCNH2POLB
SCHEMBL8233668 0.80 KMT2A (0.57) GAAKMT2AFSCN1KCNH2POLB
SCHEMBL20119975 0.80 KMT2A (0.52) GAAKMT2AFSCN1KCNH2POLB
SCHEMBL3222106 0.78 HSD17B10 (0.50) GAAKMT2AFSCN1MAPK1BLM
SCHEMBL2230513 0.78 GAA (0.96) GAAKMT2AFSCN1POLBMAPK1
SCHEMBL3976841 0.78 KMT2A (0.50) GAAKMT2AFSCN1KCNH2POLB
SCHEMBL30819523 0.78 KMT2A (0.55) GAAKMT2AFSCN1KCNH2POLB
SCHEMBL3214529 0.78 GAA (0.67) GAAKMT2AFSCN1KCNH2POLB
SCHEMBL27449226 0.78 GAA (0.55) GAAKMT2AFSCN1KCNH2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 GAA 1755/4885KMT2A 1474/4885FSCN1 4742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.